Welcome to LookChem.com Sign In|Join Free

CAS

  • or

870837-18-6

Post Buying Request

870837-18-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • SAGECHEM/3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzaldehyde/SAGECHEM/Manufacturer in China

    Cas No: 870837-18-6

  • No Data

  • No Data

  • No Data

  • SAGECHEM LIMITED
  • Contact Supplier

870837-18-6 Usage

General Description

3-Methoxy-4-(4-methyl-1H-imidazol-1-yl)benzaldehyde is a chemical compound with the molecular formula C12H12N2O2. It is a benzaldehyde derivative with a methoxy group and a substituted imidazole ring. 3-Methoxy-4-(4-methyl-1H-imidazol-1-yl)benzaldehyde is used in pharmaceutical research and drug development, specifically in the development of new therapeutic agents for various medical conditions. Its chemical structure and properties make it a valuable building block for the synthesis of novel compounds with potential biological activity. Additionally, it has been studied for its potential as an anti-inflammatory and anti-cancer agent. Further research and development of this compound may lead to new drug candidates with important clinical applications.

Check Digit Verification of cas no

The CAS Registry Mumber 870837-18-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,0,8,3 and 7 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 870837-18:
(8*8)+(7*7)+(6*0)+(5*8)+(4*3)+(3*7)+(2*1)+(1*8)=196
196 % 10 = 6
So 870837-18-6 is a valid CAS Registry Number.
InChI:InChI=1/C12H12N2O2/c1-9-6-14(8-13-9)11-4-3-10(7-15)5-12(11)16-2/h3-8H,1-2H3

870837-18-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-Methoxy-4-(4-methyl-1H-imidazol-1-yl)benzaldehyde

1.2 Other means of identification

Product number -
Other names 3-methoxy-4-(4-methylimidazol-1-yl)benzaldehyde

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:870837-18-6 SDS

870837-18-6Relevant articles and documents

Synthesis of the γ-Secretase Modulator MK-8428

Miller, Steven P.,Morris, William J.,Orr, Robert K.,Eckert, Jeffrey,Milan, Jay,Maust, Mathew,Cowden, Cameron,Cui, Jian

, p. 2957 - 2964 (2017/03/23)

The synthesis of the γ-secretase modulator MK-8428 (1) is described. The synthesis is highlighted by an enzyme-catalyzed reaction to access 3,4,5-trifluoro-(S)-phenylglycine, a 1-pot activation/displacement/deprotection sequence to introduce the aminooxy functionality and a dehydrative intramolecular cyclization under mild conditions to form the oxadiazine heterocycle of 1. In situ reaction monitoring was employed to understand the deleterious role of water during the formation of a methanesulfonate ester in the 1-pot activation/displacement/deprotection sequence.

Indolinone based LRRK2 kinase inhibitors with a key hydrogen bond

G?ring, Stefan,Taymans, Jean-Marc,Baekelandt, Veerle,Schmidt, Boris

supporting information, p. 4630 - 4637 (2015/02/05)

The most prevalent leucine-rich repeat kinase 2 (LRRK2) mutation G2019S is associated with Parkinson's disease (PD). It enhances kinase activity and has been identified in both familial and sporadic cases. Kinase activity was reported to be required for LRRK2 mutants to exert their toxic effects. Hence LRRK2 kinase inhibition may be a promising therapeutic target for PD. Here we report on the discovery and characterization of indolinone based LRRK2 inhibitors. Indolinone 15b, the most potent and selective inhibitor of the present series, is characterized by an IC50of 15 nM against wild-type LRRK2 and 10 nM against the LRRK2 G2019S mutant, respectively. Compound 15b was further evaluated in a kinase panel including 46 human protein kinases and in a zebrafish embryo phenotype assay, which enabled toxicity determination in whole organisms.

Synthesis of a potent photoreactive acidic γ-secretase modulator for target identification in cells

Rennhack, Andreas,Bulic, Bruno,Jumpertz, Thorsten,Ness, Julia,Baches, Sandra,Weggen, Sascha,Pietrzik, Claus U.

, p. 6523 - 6532,10 (2012/12/12)

Supramolecular self-assembly of amyloidogenic peptides is closely associated with numerous pathological conditions. For instance, Alzheimers disease (AD) is characterized by abundant amyloid plaques originating from the proteolytic cleavage of the amyloid precursor protein (APP) by β- and γ-secretases. Compounds named γ-secretase modulators (GSMs) can shift the substrate cleavage specificity of γ-secretase toward the production of non-amyloidogenic, shorter Aβ fragments. Herein, we describe the synthesis of highly potent acidic GSMs, equipped with a photoreactive diazirine moiety for photoaffinity labeling. The probes labeled the N-terminal fragment of presenilin (the catalytic subunit of γ-secretase), supporting a mode of action involving binding to γ-secretase. This fundamental step toward the elucidation of the molecular mechanism governing the GSM-induced shift in γ-secretase proteolytic specificity should pave the way for the development of improved drugs against AD.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 870837-18-6